Medical Equipment

Global Novel Drug Delivery Systems Market Revenue Expected To Reach $187.53 Billion By 2030

May 15, 2026May 19, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Size Is Forecasted For The Novel Drug Delivery Systems Market By 2030 Based On Its 2026 Value?

The novel drug delivery systems market size has seen rapid expansion over recent years. It is anticipated to increase from $117.66 billion in 2025 to $129.45 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.0%. The historical growth of this market can be attributed to several factors including the rising prevalence of chronic diseases, the limitations inherent in conventional drug delivery techniques, an expanding pipeline in oncology and biologics, escalating healthcare expenditure, and breakthroughs in polymer and nanotechnology.

The novel drug delivery systems market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $187.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.7%. Factors contributing to this growth include a rise in personalized and precision medicine, increased demand for targeted cancer treatments, greater investment in pharmaceutical research and development, the broadening scope of biologics and biosimilars, and supportive regulations for cutting-edge drug delivery technologies. Key trends expected during this period involve the growth of targeted and personalized drug delivery methods, increasing use of lipid and polymeric nanoparticles, the development of long-acting and controlled-release formulations, a heightened emphasis on non-invasive and patient-focused delivery pathways, and intensified research and development in combination and hybrid novel drug delivery system platforms.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25850&type=smp

What Are The Main Drivers Accelerating The Growth Of The Novel Drug Delivery Systems Market?

The prevalence of neurological disorders is projected to boost the growth of the novel drug delivery systems market moving forward. A neurological disorder, such as a stroke, constitutes a medical condition marked by an abrupt loss of neurological function, resulting from an interruption of blood supply to the brain due to either a blockage (ischemic stroke) or a ruptured blood vessel (hemo**rr**hagic stroke), which causes brain tissue damage and potentially enduring cognitive, sensory, or motor impairments. The increasing occurrence of neurological disorders is primarily influenced by factors like aging populations, a higher incidence of lifestyle conditions such as hypertension, diabetes, and obesity, and increased exposure to chronic stress and environmental risk factors. Novel drug delivery systems offer a solution for managing neurological disorders by enabling the targeted and controlled delivery of therapeutics across the blood-brain barrier. For instance, in November 2024, the National Health Service (NHS) England, a UK-based healthcare system, reported that stroke admissions in England increased to 111,137 in 2023/24, with the 50–59 age group showing the highest rise at 12,533 cases. Thus, the growing number of neurological disorder cases is stimulating the growth of the novel drug delivery systems market.

Which Segment Groups Define The Novel Drug Delivery Systems Market Landscape?

The novel drug delivery systems market covered in this report is segmented –

1) By Formulation Type: Liposomes, Nanoparticles, Microspheres, Hydrogels, Dendrimers

2) By Mode Of Novel Drug Delivery System (NDDS): Targeted Drug Delivery Systems, Controlled Drug Delivery Systems, Modulated Drug Delivery Systems

3) By Route: Oral Drug Delivery Systems, Injectable Drug Delivery Systems, Pulmonary Drug Delivery Systems, Transdermal Drug Delivery Systems, Other Routes

4) By Therapeutic Area: Cancer, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Autoimmune Diseases

5) By End-User: Hospital, Specialty Clinics, Research Centers, Other End-Users

Subsegments:

1) By Liposomes: PEGylated Liposomes, Cationic Liposomes, Stealth Liposomes, Immunoliposomes

2) By Nanoparticles: Polymeric Nanoparticles, Lipid Nanoparticles, Metallic Nanoparticles, Nanocrystals

3) By Microspheres: Biodegradable Microspheres, Magnetic Microspheres, Radioactive Microspheres, Mucoadhesive Microspheres

4) By Hydrogels: Thermosensitive Hydrogels, Ph-Responsive Hydrogels, Injectable Hydrogels, Smart Hydrogels

5) By Dendrimers: PAMAM Dendrimers, PPI Dendrimers, Pegylated Dendrimers, Hybrid Dendrimers

What Trends Are Driving Changes In The Novel Drug Delivery Systems Market?

Leading companies in the novel drug delivery systems market are prioritizing the development of innovative solutions, such as oral thin films, to improve patient adherence and therapeutic efficacy. An oral thin film represents a drug delivery mechanism comprising a quickly dissolving film strip applied in the oral cavity, engineered to release medication directly into the bloodstream through the mucosal membrane. As an illustration, in February 2024, CD Formulation, a US-based pharmaceutical formulation company, introduced its Oral Thin Film Technology. This product facilitates swift drug absorption by circumventing gastrointestinal and liver metabolism, making it especially advantageous for patients experiencing swallowing difficulties. Additionally, it supports precise dosing and a more rapid onset of action, thereby enhancing treatment accuracy and convenience across diverse therapeutic applications.

Which Industry Players Are Present In The Novel Drug Delivery Systems Market?

Major companies operating in the novel drug delivery systems market are Pfizer Inc, Johnson And Johnson, F Hoffmann La Roche AG, Merck And Co Inc, AbbVie Inc, Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Gilead Sciences, Amgen Inc, Teva Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co Ltd, Regeneron Pharmaceuticals, Samyang Holdings Corporation, Galen Limited, Catalent Inc, Evonik Industries AG

Access The Complete Novel Drug Delivery Systems Market Report:

https://www.thebusinessresearchcompany.com/report/novel-drug-delivery-systems-global-market-report

Which Region Stands As The Largest Contributor To The Novel Drug Delivery Systems Market?

North America was the largest region in the novel drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the novel drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Novel Drug Delivery Systems Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/novel-drug-delivery-systems-global-market-report

Browse Through More Reports Similar to the Global Novel Drug Delivery Systems Market 2026, By The Business Research Company

Electronic Drug Delivery Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/electronic-drug-delivery-systems-global-market-report

Pharmaceutical Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Smart Drug Delivery Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-drug-delivery-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795